search
Back to results

Information Presentation Formats

Primary Purpose

Meningioma

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Check Symptoms
Uncheck Symptoms
Experienced
Not Experienced
Sponsored by
Carnegie Mellon University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Meningioma focused on measuring Symptom Assessment

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • 18 or older
  • American

Exclusion Criteria:

  • Mechanical Turk approval rate below 95%

Sites / Locations

  • Carnegie Mellon University

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

Experimental

Arm Label

Check/Experience

Un-check/Experience

Check/Not Experienced

Un-check/Not Experienced

Arm Description

Participants are asked to check the symptoms that they have experienced in the last 6 weeks.

Participants are asked to un-check the symptoms that they have experienced in the last 6 weeks.

Participants are asked to check the symptoms that they have NOT experienced in the last 6 weeks.

Participants are asked to un-check the symptoms that they have NOT experienced in the last 6 weeks.

Outcomes

Primary Outcome Measures

Number of symptoms
The number of symptoms checked off by participants
Risk of meningioma
Self-reported perceived risk of meningioma
Information pursuit
Binary measure of whether participants click to receive information about meningioma

Secondary Outcome Measures

Funding allocation
Hypothetical federal funding allocation to meningioma
Risk of serious disease
Perceived risk of having any serious disease

Full Information

First Posted
October 14, 2014
Last Updated
August 1, 2016
Sponsor
Carnegie Mellon University
search

1. Study Identification

Unique Protocol Identification Number
NCT02267928
Brief Title
Information Presentation Formats
Official Title
Information Presentation Formats and Pursuit of Diagnostic Information
Study Type
Interventional

2. Study Status

Record Verification Date
August 2016
Overall Recruitment Status
Completed
Study Start Date
October 2014 (undefined)
Primary Completion Date
March 2016 (Actual)
Study Completion Date
May 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Carnegie Mellon University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Prevention and early detection of medical problems can greatly reduce health care costs, yet time and again, people avoid or ignore services that could help detect medical problems early enough to prevent or reduce the severity of potential problems. The investigators seek to understand whether the elicitation of symptom admission by patients can predict people's perceived risk of the medical condition and voluntary pursuit of medical information.
Detailed Description
We will present individuals with medically accurate information about a medical condition and measure people's perceptions of their own likelihood to having that medical condition. This will include an opportunity for people to pursue more information by directing them to a website that features more information about the condition. The initial information provision will vary slightly in presentation (method of eliciting symptoms will vary), and the rate at which individuals visit the subsequent medical website to receive more information will be recorded as a measure of information seeking behavior. Rates will be compared across symptom elicitation conditions to determine which formats are most effective at encouraging information seeking about health issues. No personally identifying information will be collected, and all results will be reported in aggregate. Critically, no deception will be used: Participants will only be provided with information that is as accurate as possible (given existing knowledge in the health/medical fields).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Meningioma
Keywords
Symptom Assessment

7. Study Design

Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
Participant
Allocation
Randomized
Enrollment
305 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Check/Experience
Arm Type
Experimental
Arm Description
Participants are asked to check the symptoms that they have experienced in the last 6 weeks.
Arm Title
Un-check/Experience
Arm Type
Experimental
Arm Description
Participants are asked to un-check the symptoms that they have experienced in the last 6 weeks.
Arm Title
Check/Not Experienced
Arm Type
Experimental
Arm Description
Participants are asked to check the symptoms that they have NOT experienced in the last 6 weeks.
Arm Title
Un-check/Not Experienced
Arm Type
Experimental
Arm Description
Participants are asked to un-check the symptoms that they have NOT experienced in the last 6 weeks.
Intervention Type
Other
Intervention Name(s)
Check Symptoms
Intervention Description
Symptoms are "Checked"
Intervention Type
Other
Intervention Name(s)
Uncheck Symptoms
Intervention Description
Symptoms are "Un-checked"
Intervention Type
Other
Intervention Name(s)
Experienced
Intervention Description
Focus of instructions is on symptoms the participant has experienced
Intervention Type
Other
Intervention Name(s)
Not Experienced
Intervention Description
Focus of instructions is on symptoms the participant has NOT experienced
Primary Outcome Measure Information:
Title
Number of symptoms
Description
The number of symptoms checked off by participants
Time Frame
1 day
Title
Risk of meningioma
Description
Self-reported perceived risk of meningioma
Time Frame
1 day
Title
Information pursuit
Description
Binary measure of whether participants click to receive information about meningioma
Time Frame
1 day
Secondary Outcome Measure Information:
Title
Funding allocation
Description
Hypothetical federal funding allocation to meningioma
Time Frame
1 day
Title
Risk of serious disease
Description
Perceived risk of having any serious disease
Time Frame
1 day

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 18 or older American Exclusion Criteria: Mechanical Turk approval rate below 95%
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eric M VanEpps, MS
Organizational Affiliation
Carnegie Mellon University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Carnegie Mellon University
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Information Presentation Formats

We'll reach out to this number within 24 hrs